Evidence map›Paper›PMID 24516023›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Biomarkers to the rescue in a lung nodule epidemic.

Pierre P Massion

Registry-linked trialAbstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07615556 (Circulating Tumor DNA Mutations and Methylation Status as Biomarkers for Early Detection of Lung Cancer in Patients With Suspicious Lung Nodules), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07615556 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Circulating Tumor DNA Mutations and Methylation Status as Biomarkers for Early Detection of Lung Cancer in Patients With Suspicious Lung Nodules

Typeobservational_patient_registrySponsorThe University of Hong KongRan2026 to 2028Enrolled200ConditionsLung Nodules, Lung Cancer Screening, Suspected Lung CancerArmsctDNA mutations and methylation with SPOTMAS Lung assays, Non-contrast LDCT Thorax scans
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Comparative Microbiomics Analysis of Antimicrobial Antibody Response between Patients with Lung Cancer and Control Subjects with Benign Pulmonary Nodules.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Update in Lung Cancer 2014.American journal of respiratory and critical care medicine · 2015
    Review
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Pierre P MassionVanderbilt Ingram Cancer Center, Nashville, TN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene Expression ProfilingTomography, X-Ray ComputedBiomarkers, TumorFemaleGenetic TestingHumansLung NeoplasmsMaleMass ScreeningMicroRNAsBiomarkers, TumorMicroRNAs

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.